These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30647035)

  • 21. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
    Lv J; Zhang H; Wong MG; Jardine MJ; Hladunewich M; Jha V; Monaghan H; Zhao M; Barbour S; Reich H; Cattran D; Glassock R; Levin A; Wheeler D; Woodward M; Billot L; Chan TM; Liu ZH; Johnson DW; Cass A; Feehally J; Floege J; Remuzzi G; Wu Y; Agarwal R; Wang HY; Perkovic V;
    JAMA; 2017 Aug; 318(5):432-442. PubMed ID: 28763548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation.
    Tang Z; Ji SM; Chen DR; Wen JQ; Chen JS; Liu ZH; Li LS
    Ren Fail; 2008; 30(6):611-6. PubMed ID: 18661411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the diagnosis of glomerular diseases in east China: a 15-year renal biopsy study.
    Zhou Q; Yang X; Wang M; Wang H; Zhao J; Bi Y; Wang X; Yao J; Chen Y; Lin C; Xie X; Jiang H; Chen J
    Ren Fail; 2018 Nov; 40(1):657-664. PubMed ID: 30484732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrarenal Arterial Lesions Are Associated with Higher Blood Pressure, Reduced Renal Function and Poorer Renal Outcomes in Patients with IgA Nephropathy.
    Zhang Y; Sun L; Zhou S; Xu Q; Xu Q; Liu D; Liu L; Hu R; Quan S; Xing G
    Kidney Blood Press Res; 2018; 43(2):639-650. PubMed ID: 29698975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study.
    Okabayashi Y; Tsuboi N; Amano H; Miyazaki Y; Kawamura T; Ogura M; Narita I; Ninomiya T; Yokoyama H; Yokoo T
    BMJ Open; 2018 Oct; 8(10):e024317. PubMed ID: 30385449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
    Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Application of the Oxford classification of IgA nephropathy to predict renal outcome].
    Peng YH; Su Y; Zhao YJ; Lin CN; Sun GF; Li H; Yu Y; Huang QY; Ye W; Li XM; Li XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):102-7. PubMed ID: 23469800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP; van den Brand JA; Berger SP; Wetzels JF
    Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study.
    Pan M; Zhou Q; Zheng S; You X; Li D; Zhang J; Chen C; Xu F; Li Z; Zhou Z; Zhang J
    Immunol Res; 2018 Jun; 66(3):381-391. PubMed ID: 29850970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy.
    Liu Y; Wei W; Yu C; Xing L; Wang M; Liu R; Ma J; Liu X; Xie R; Sui M
    Med Clin (Barc); 2021 Sep; 157(6):267-273. PubMed ID: 32826075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and pathological analysis of 217 patients with IgA nephropathy from Hainan Province].
    Fu KY; Chen R; Zhan F; Cai JH; Xie YY; Wu Y; Han YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1445-7. PubMed ID: 19620078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T; Najafi I; Salimi BH; Broomand B
    Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The precise long-term outcomes of adult IgA nephropathy by mail questionnaires: Better renal survival compared to earlier cohort studies.
    Imai E; Usui J; Kaneko S; Kawamura T; Suka M; Yamagata K
    PLoS One; 2020; 15(5):e0233186. PubMed ID: 32413080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cigarette smoking and progression of IgA nephropathy.
    Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
    Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of high body mass index with development of interstitial fibrosis in patients with IgA nephropathy.
    Wu C; Wang AY; Li G; Wang L
    BMC Nephrol; 2018 Dec; 19(1):381. PubMed ID: 30594167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W; Liang S; Hu Y; Deng K; Bao H; Zeng C; Liu Z
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S; Lundahl J; Gunnarsson I; Sundelin B; Jacobson SH
    Nephrol Dial Transplant; 2012 May; 27(5):1916-23. PubMed ID: 21940483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-related differences in clinicopathological characteristics and renal outcomes of Chinese patients with IgA nephropathy.
    Deng W; Tan X; Zhou Q; Ai Z; Liu W; Chen W; Yu X; Yang Q
    BMC Nephrol; 2018 Feb; 19(1):31. PubMed ID: 29415664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Imafuku A; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabet Med; 2015 Apr; 32(4):546-55. PubMed ID: 25400024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgA nephropathy: the presence of familial disease does not confer an increased risk for progression.
    Izzi C; Ravani P; Torres D; Prati E; Viola BF; Guerini S; Foramitti M; Frascà G; Amoroso A; Ghiggeri GM; Schena FP; Scolari F
    Am J Kidney Dis; 2006 May; 47(5):761-9. PubMed ID: 16632014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.